C5 (Eculizumab Biosimilar) Anticorps
(C5 (Eculizumab Biosimilar))
The protein encoded by this gene is the fifth component of complement, which plays an important role in inflammatory and cell killing processes. This protein is comprised of alpha and beta polypeptide chains that are linked by a disulfide bridge. An activation peptide, C5a, which is an anaphylatoxin that possesses potent spasmogenic and chemotactic activity, is derived from the alpha polypeptide via cleavage with a convertase. The C5b macromolecular cleavage product can form a complex with the C6 complement component, and this complex is the basis for formation of the membrane attack complex, which includes additional complement components. Mutations in this gene cause complement component 5 deficiency, a disease where patients show a propensity for severe recurrent infections. Defects in this gene have also been linked to a susceptibility to liver fibrosis and to rheumatoid arthritis. [provided by RefSeq, Jul 2008].
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
C5 (Eculizumab Biosimilar) recommandé Anticorps
Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Application
FACS, in vivo
Validations
N° du produit
ABIN7200672
Quantité
1 mg
Fiche technique
Fiche technique
Reactivity
Human
Application
Validations
N° du produit
ABIN7487797
Quantité
100 μg
Fiche technique
Fiche technique
Synonymes et noms alternatifs relatifs à C5 (Eculizumab Biosimilar)
complement C5 (C5), C5a, C5b, CPAMD4Protein level used designations for C5 (Eculizumab Biosimilar)
- C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4
- C5a anaphylatoxin
- anaphylatoxin C5a analog
- complement C5
- prepro-C5
Vous êtes ici:
